Description
HIV p17 Gag (77-85) is an immunodominant Gag epitope peptide used to prime activated CD8+ cytotoxic T cells (CTLs) in the design of vaccines against HIV-1.
HIV p17 Gag (77-85)
Product ID H3274
Cas No.
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Purity | ≥98% |
|---|---|
| Formula | C44H72N10O15 |
| Formula Wt. | 981.1 |
| Synonym | HIV-1 p17 (77-85), SL9. |
| Solubility | Soluble in water, DMSO. |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| Info Sheet |
|---|
References
Kan-Mitchell J, Bajcz M, Schaubert KL, et al. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol. 2006 Jun 1;176(11):6690-701. PMID: 16709828.
Kan-Mitchell J, Bisikirska B, Wong-Staal F, et al. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol. 2004 May 1;172(9):5249-61. PMID: 15100263.